Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. (2022)
Attributed to:
A Dose Reduction Immunobridging Study of two HPV vaccines in Tanzanian girls
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2214-109x(22)00306-0
PubMed Identifier: 36113532
Publication URI: http://europepmc.org/abstract/MED/36113532
Type: Journal Article/Review
Volume: 10
Parent Publication: The Lancet. Global health
Issue: 10
ISSN: 2214-109X